Simile
An AI research platform built around simulated users for product and market research.
The Company
Simile uses AI agents to simulate users for product and market research. The company positions the platform as a faster complement to conventional research workflows, where teams need repeated feedback on messaging, concepts, and product decisions.
The company announced a $200 million Series B at a $2 billion valuation in July 2026, led by Greenoaks. It followed a $100 million Series A announced five months earlier, making the pace of financing itself a notable part of the profile.
Why It Matters
Synthetic research is an emerging application layer for AI, where value depends on whether simulated behavior is decision-useful rather than merely convincing. Simile is a high-profile private-market test of that proposition.
Valuation History
- $2.0B→Jul 2026$200M Series BSource ↗
What Changed
Simile announced a $200M Series B at a $2B valuation, led by Greenoaks.
THE NEXT COMPANY. A CLEARER PICTURE.
Get the next breakdown.
Independent company research and perspectives on private markets, delivered through The Private Ledger on Substack.